Want to join the conversation?
In 4Q16, $EXAR said GM was up 144BP sequentially. The company generated $4.3MM in free cash flow and made payments to settle a pending lawsuit for $1.7MM resulting in a cash balance of $55MM. $EXAR signed an agreement for the sale-leaseback of its corporate facility for a sales price of $26MM.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.